Kercheville Advisors, LLC Biogen Inc. Transaction History

Kercheville Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 26, 2022	SELL	$223.92 - $287.77 $214,963 - $276,259	-960 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $56,598 - $73,810	-200 Reduced 17.24%	960 $272,000
Q2 2021 Nov 15, 2021	SELL	$259.0 - $414.71 $16,835 - $26,956	-65 Reduced 5.31%	1,160 $402,000
Q1 2021 Nov 15, 2021	BUY	$242.95 - $284.63 $297,613 - $348,671	1,225 New	1,225 $344,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Kercheville Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Kercheville Advisors, LLC with notifications on news.